Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized CONSORT-based dosing of GONAL-f vs standard 150 IU in ART
2008-001259-22Phase 4Completed
- Sponsor
- Merck Serono
- Start
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of follitropin alfa in infertility and None (2 arms), sponsored by Merck Serono. Primary endpoint: Primary efficacy and safety endpoints. Started Jun 2008; status: completed.
02
Drugs
follitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on 2008-001259-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001259-22.